% | $
Quotes you view appear here for quick access.

BioTelemetry, Inc. Message Board

  • drdave01 drdave01 Jul 28, 2010 2:24 PM Flag

    This Quarter

    Any projections for the earnings to be released in a couple of hours? Patient volume growth, cash flow, new product R&D? Will there be any hints at strategic partner interest?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • unimpressive volume growth, but impressive free cash flow. they are profitable even with all the disasters around them. and sitting on $2/share in cash.

      • 1 Reply to jerrywang99
      • Cash flow increased because revenue decreased and A/R decreased. When a business is shrinking it throws off cash! Very UNimpressive patient volume growth and with Q to Q revenue declining from Q1 to Q2...especially UNimpressive revenue, since Q2 was operating under similar reimbursement as Q1 implying no patient growth from Q1 to Q2; I am sure that was fleshed out more specifically in the CC since it was not discussed in the PR (for obvious reasons!)

        As for GE or anyone acquiring this.....can you spell H U G E class action lawsuit?? No acquisition till this is settled and you may see their balance sheet change drastically!

    • My hunch is that they will "clear the decks" by writing off everything they can and take the largest loss possible so they can then, hopefully, show some improvement going forward. This would tend to be a common approach when a new #1 is in charge, since he can claim this was not his fault, but he is just cleaning up the mess he was dealt with. They had originally indicated they hoped to show an "operating profit" (not sure what that means these days) by they will accelerate as many expenses and postpone as much revenue as they can (Oh...I forgot, that is illegal these days....)

9.18-0.23(-2.44%)Jul 2 4:00 PMEDT